S van Deventer

520 total citations
11 papers, 402 citations indexed

About

S van Deventer is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, S van Deventer has authored 11 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 3 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in S van Deventer's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). S van Deventer is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). S van Deventer collaborates with scholars based in Netherlands, Ireland and United States. S van Deventer's co-authors include G Tremblay, N. van den Bulk, Diane Brisson, J. de Wal, Karine Tremblay, Jaap Twisk, Julie Méthot, Daniel Gaudet, S. Déry and Urs Widmer and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Gene Therapy.

In The Last Decade

S van Deventer

11 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S van Deventer Netherlands 6 216 185 117 85 78 11 402
J. de Wal Canada 4 275 1.3× 270 1.5× 226 1.9× 122 1.4× 85 1.1× 8 519
Yoshifumi Ohnishi Japan 7 151 0.7× 179 1.0× 32 0.3× 88 1.0× 70 0.9× 13 459
Maria Grazia Franzosi Italy 5 199 0.9× 284 1.5× 89 0.8× 94 1.1× 13 0.2× 8 537
Jessie J.‐Y. Chang Australia 6 102 0.5× 351 1.9× 37 0.3× 49 0.6× 130 1.7× 10 472
Frank Dastvan United States 9 34 0.2× 223 1.2× 64 0.5× 58 0.7× 36 0.5× 9 418
Hassan Foroughi Asl Sweden 10 93 0.4× 205 1.1× 39 0.3× 56 0.7× 16 0.2× 15 364
Adrien Lupieri United States 9 59 0.3× 108 0.6× 54 0.5× 24 0.3× 28 0.4× 16 278
Matthew P. Vasievich United States 9 45 0.2× 166 0.9× 37 0.3× 54 0.6× 25 0.3× 12 407
Sophie Bérissi France 6 59 0.3× 159 0.9× 20 0.2× 70 0.8× 26 0.3× 7 396
Adi Egozi Israel 7 112 0.5× 245 1.3× 11 0.1× 137 1.6× 83 1.1× 13 475

Countries citing papers authored by S van Deventer

Since Specialization
Citations

This map shows the geographic impact of S van Deventer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S van Deventer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S van Deventer more than expected).

Fields of papers citing papers by S van Deventer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S van Deventer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S van Deventer. The network helps show where S van Deventer may publish in the future.

Co-authorship network of co-authors of S van Deventer

This figure shows the co-authorship network connecting the top 25 collaborators of S van Deventer. A scholar is included among the top collaborators of S van Deventer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S van Deventer. S van Deventer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Deventer, S van, et al.. (2013). Case report: Giant lipoma of the hand. The South African Orthopaedic Journal (SAOJ). 12(3). 46–48. 3 indexed citations
2.
Gaudet, Daniel, Julie Méthot, S. Déry, et al.. (2012). Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Therapy. 20(4). 361–369. 302 indexed citations
4.
Braat, Henri, Pieter Rottiers, Nathalie Huyghebaert, et al.. (2005). Interleukin-10 producing Lactococcus lactis for the treatment of Crohn??s disease. European Journal of Gastroenterology & Hepatology. 18(1). A18–A18. 6 indexed citations
5.
Kort, Floor de, Inge Pronk, Anje A. te Velde, et al.. (2005). Functional consequences of NOD2 deficiency in Crohn??s disease patients peripheral blood monocytes derived dendritic cells. European Journal of Gastroenterology & Hepatology. 18(1). A29–A29. 3 indexed citations
6.
Löwenberg, Mark, Auke P. Verhaar, Bernt van den Blink, et al.. (2005). Essential role for c-Raf in steroid insensitive Crohn??s disease. European Journal of Gastroenterology & Hepatology. 18(1). A27–A28. 1 indexed citations
7.
Braat, Henri, et al.. (2005). Turbo-probiotics as a tool for cell-based (mucosal) delivery of interleukin-10. European Journal of Gastroenterology & Hepatology. 18(1). A28–A28. 3 indexed citations
8.
D’Haens, G., Isolde Aerden, John B. Kisiel, et al.. (1999). Duration of response following cessation of infliximab therapy for active or fistulizing Crohn's disease. Gastroenterology. 116(4). 15 indexed citations
9.
D’Haens, G., et al.. (1998). Anti-TNFα monoclonal antibody (cA2) produces endoscopic healing in patients with treatment-resistant, active Crohn's disease. Gastroenterology. 114. A964–A964. 7 indexed citations
10.
Fedorak, Richard N., Alfred Gangl, Paul Rutgeerts, et al.. (1998). Safety, tolerance and efficacy of multiple doses of subcutaneous interleukin-10 in mild to moderate active Crohn's disease (STAMM-CD). Gastroenterology. 114. A974–A974. 18 indexed citations
11.
Widmer, Urs, Zhaohai Yang, S van Deventer, et al.. (1991). Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78. The Journal of Immunology. 146(11). 4031–4040. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026